Mirodenafil vs Tadalafil

Mirodenafil wins for fast onset, short half-life (2.5 h), superior PDE5 selectivity, and minimal PDE6/vision side effects. Ideal for those needing clean offset before sleep or wanting fewer lingering effects compared to other PDE5 inhibitors.

Tadalafil wins for long, stable action (~17.5 h half-life), daily low-dose convenience, robust evidence for cardiovascular and BPH support, and global sourcing. Its predictable profile makes it the default backbone for year-round BP and vascular support in aesthetics-focused protocols.

Pick Mirodenafil if:

• Short-acting, on-demand PDE5 inhibition is desired with bedtime offset (events, pre-workout, etc).
• Previous issues occurred with sildenafil-induced flushing or visual disturbances.
• A cleaner selectivity profile (lower risk of non-target PDE inhibition) is preferred.
• Sourcing from Korean generics is accessible.
• A daily protocol is wanted without the 36-hour shadow effect associated with tadalafil.

Pick Tadalafil if:

• Stable, round-the-clock PDE5 inhibition is the goal (BP, pump, or scalp blood flow support).
• Minimal impact from meal timing and alcohol is desired for flexible dosing.
• Proven year-round, daily 5 mg protocol with reliable global sourcing is needed.
• Support for BPH/LUTS is a goal in addition to vascular/performance outcomes.
• Convenience and evidence depth of a legacy compound is a top priority.